Temozolomide (Temodar™).
- Published in:
- Clinical Journal of Oncology Nursing, 2001, v. 5, n. 1, p. 3
- By:
- Publication type:
- Article
Works matching DE "BAYER HealthCare Pharmaceuticals Inc."
Results: 76
1
2
From Propaganda to scientific marketing: Schering, cortisone, and the construction of drug markets.
- Published in:
- History & Technology, 2013, v. 29, n. 2, p. 188, doi. 10.1080/07341512.2013.828510
- By:
- Publication type:
- Article
3
Bayer Schering Pharma AG v. Barr Laboratories, Inc.
- Published in:
- New York Law School Law Review, 2010, v. 55, n. 1, p. 399
- By:
- Publication type:
- Article
4
European Weed Research Society.
- Published in:
- 1984
- Publication type:
- Other
5
Pain free manufacturing [production facility for pharmaceutical industry].
- Published in:
- Manufacturing Engineer, 2006, v. 85, n. 5, p. 24, doi. 10.1049/me:20060505
- By:
- Publication type:
- Article
6
Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma.
- Published in:
- Journal of Neuro-Oncology, 2009, v. 91, n. 1, p. 47
- By:
- Publication type:
- Article
7
Big business takeovers and assisted human conception.
- Published in:
- Reproductive BioMedicine Online (Reproductive Healthcare Limited), 2006, v. 12, n. 5, p. 643
- Publication type:
- Article
8
Viagra Gets Out of the Game.
- Published in:
- Journal of Sport & Social Issues, 2007, v. 31, n. 2, p. 101, doi. 10.1177/0193723507302958
- By:
- Publication type:
- Article
9
Product Preview.
- Published in:
- 2005
- Publication type:
- Product Review
10
Product Preview.
- Published in:
- Urology Times, 2004, v. 32, n. 1, p. 24
- Publication type:
- Article
11
New Products & Services.
- Published in:
- Urology Times, 2003, v. 31, n. 10, p. 60
- Publication type:
- Article
12
The MS Technology Collaborative.
- Published in:
- Inside MS, 2007, v. 25, n. 4, p. 28
- Publication type:
- Article
13
FGF-4 Gene Therapy GENERX - Collateral Therapeutics: Ad5FGF4, Fibroblast Growth Factor-4 Gene Therapy GENERX - Collateral Therapeutics, GENERX.
- Published in:
- BioDrugs, 2002, v. 16, n. 1, p. 75, doi. 10.2165/00063030-200216010-00010
- Publication type:
- Article
14
Important Changes in the Moxifloxacin Hydrochloride and Ciprofloxacin Prescribing Information. Addition of Boxed Warning Regarding Myasthenia Gravis Exacerbation.
- Published in:
- 2011
- Publication type:
- Letter
15
Internationale Marketingstrategien und Marketing-Informationssysteme der westdeutschen Pharmaindustrie in den 1950er bis 70er Jahren: Eine 'Marketing-Informationsrevolution'?
- Published in:
- Jahrbuch für Wirtschaftsgeschichte, 2015, v. 56, n. 1, p. 137, doi. 10.1515/jbwg-2015-0006
- By:
- Publication type:
- Article
16
Sorafenib prolongs survival in renal cell carcinoma.
- Published in:
- Expert Review of Pharmacoeconomics & Outcomes Research, 2007, v. 7, n. 1, p. 7
- Publication type:
- Article
17
FDA approves combination oral contraceptive.
- Published in:
- Contemporary OB/GYN, 2010, v. 55, n. 7, p. 12
- Publication type:
- Article
18
Alfa interferons: labelling change.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 1, p. 27
- Publication type:
- Article
19
KEEP CALM AND CARRY ON.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 832, p. 72
- Publication type:
- Article
20
PCMs, tablets and biomonitors listed for Zukunftspreis.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 821, p. 70
- Publication type:
- Article
21
Bayer Healthcare Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc.: Was the decision to selectively present evidence of commercial success too “clever by half”?
- Published in:
- 2013
- By:
- Publication type:
- Case Study
22
Practical experience with the serials control package `SAILS'.
- Published in:
- Serials Librarian, 1995, v. 26, n. 2, p. 75, doi. 10.1300/J123v26n02_07
- By:
- Publication type:
- Article
23
Intravascular contrast agent T1 shortening: fast T1 relaxometry in a carotid volunteer study.
- Published in:
- MAGMA: Magnetic Resonance Materials in Physics, Biology & Medicine, 2008, v. 21, n. 5, p. 363, doi. 10.1007/s10334-008-0134-2
- By:
- Publication type:
- Article
24
Green Pastures for Discovery Informatics.
- Published in:
- Bio-IT World, 2005, v. 4, n. 5, p. 38
- By:
- Publication type:
- Article
25
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 12, doi. 10.1038/nrd3077
- Publication type:
- Article
26
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 7, p. 530, doi. 10.1038/nrd2105
- Publication type:
- Article
27
How Bayer Makes Decisions to Develop New Drugs.
- Published in:
- Interfaces, 2002, v. 32, n. 6, p. 77, doi. 10.1287/inte.32.6.77.6475
- By:
- Publication type:
- Article
28
Safety, Efficacy, and Patient and Partner Acceptability of Vardenafil Orally Disintegrating Tablets for the Treatment of Erectile Dysfunction.
- Published in:
- Clinical Medicine Reviews in Therapeutics, 2013, v. 5, p. 1, doi. 10.4137/CMRT.S7349
- By:
- Publication type:
- Article
29
4th European Symposium on the Application of Saliva in Clinical Practice and Research.
- Published in:
- European Journal of Oral Sciences, 1995, v. 103, n. 2p2, p. S1, doi. 10.1111/j.1600-0722.1995.tb00130.x
- Publication type:
- Article
30
PHYSIOLOGICAL EFFECTS OF CONTRACEPTIVES.
- Published in:
- Ethics & Medics, 2013, v. 38, n. 10, p. 1, doi. 10.5840/em2013381015
- By:
- Publication type:
- Article
31
A hard pill to swallow: Does Schering v Geneva endanger innovation within the pharmaceutical industry?
- Published in:
- Journal of Intellectual Property Rights, 2007, v. 12, n. 3, p. 358
- Publication type:
- Article
32
NICE recommends all patients admitted to hospital are risk assessed for VTE.
- Published in:
- Operating Theatre Journal, 2010, n. 233, p. 3
- Publication type:
- Article
33
News Update.
- Published in:
- Applied Clinical Trials, 2003, v. 12, n. 2, p. 16
- Publication type:
- Article
34
Trials in progress.
- Published in:
- Applied Clinical Trials, 2002, v. 11, n. 11, p. 14
- Publication type:
- Article
35
ACKNOWLEDGEMENT.
- Published in:
- Journal of Investigative Dermatology, 1995, v. 104, n. 5, p. 705, doi. 10.1111/1523-1747.ep12606949
- By:
- Publication type:
- Article
36
ACKNOWLEDGMENT.
- Published in:
- 1993
- By:
- Publication type:
- Other
37
New drugs and dosage forms.
- Published in:
- 2009
- Publication type:
- Product Review
38
RFID technology may improve contrast agent safety.
- Published in:
- American Journal of Health-System Pharmacy, 2008, v. 65, n. 15, p. 1400, doi. 10.2146/news080064
- By:
- Publication type:
- Article
39
News Briefs.
- Published in:
- American Journal of Health-System Pharmacy, 2007, v. 64, n. 10, p. 1028
- Publication type:
- Article
40
Bulletin Board.
- Published in:
- Journal of Women's Health (15409996), 2010, v. 19, n. 7, p. 1227, doi. 10.1089/jwh.2010.BB07
- Publication type:
- Article
41
TECHNOLOGY & INDUSTRY.
- Published in:
- Applied Radiology, 2004, v. 33, n. 5, p. 47
- Publication type:
- Article
42
New drug launched in the UK for treatment of hepatocellular carcinoma.
- Published in:
- Expert Review of Anticancer Therapy, 2007, v. 7, n. 12, p. 1697
- Publication type:
- Article
43
Pharmaceutical mega-deals get go ahead.
- Published in:
- Chemistry & Industry, 2009, n. 21, p. 5
- Publication type:
- Article
44
Bioproducts in brief.
- Published in:
- Chemistry & Industry, 2008, n. 11, p. 11
- Publication type:
- Article
45
Bayer, Bollywood and Big Bucks.
- Published in:
- Chemistry & Industry, 2008, n. 5, p. 7
- By:
- Publication type:
- Article
46
800 jobs lost due to R&D consolidation.
- Published in:
- Chemistry & Industry, 2006, n. 23, p. 8
- By:
- Publication type:
- Article
47
Movers & Shakers.
- Published in:
- Chemistry & Industry, 2006, n. 19, p. 38
- Publication type:
- Article
48
Business Digest.
- Published in:
- Chemistry & Industry, 2006, n. 13, p. 11
- Publication type:
- Article
49
Bayer and Merck meet head on.
- Published in:
- Chemistry & Industry, 2006, n. 12, p. 9
- By:
- Publication type:
- Article
50
Bayer's heavyweigth buy.
- Published in:
- Chemistry & Industry, 2006, n. 7, p. 9
- By:
- Publication type:
- Article